Specifically, patients with severe disease have <5% of the normal quantity of dystrophin, whereas patients with dystrophin levels between 5% and 10% of normal, regardless of protein size, usually have an intermediate phenotype (mild DMD or severe BMD). The gene discussed is DMD; the disease is Duchenne muscular dystrophy.